Monoclonal gammopathies of renal significance

被引:4
|
作者
Gnanasampanthan, Sahana [1 ]
Kousios, Andreas [1 ,2 ,3 ]
机构
[1] Hammersmith Hosp, Imperial Coll Healthcare NHS Trust, London, England
[2] Imperial Coll, London, England
[3] Hammersmith Hosp, Imperial Coll Healthcare NHS Trust, West London Renal & Transplant Ctr, Du Cane Rd, London W10 0HS, England
关键词
Paraprotein-related renal disease; monoclonal immunoglobulins; monoclonal gammopathies of renal significance; Bence-jones protein; chronic kidney disease; PROLIFERATIVE GLOMERULONEPHRITIS;
D O I
10.7861/clinmed.2023-RM3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The term monoclonal gammopathies of renal significance (MGRS) encompasses a group of renal histopathological lesions fulfilling two criteria: (a) they are caused by nephrotoxic monoclonal immunoglobulins and (b) the monoclonal immunoglobulins are produced by small B-cell or plasma cell clones which do not meet the criteria for multiple myeloma or malignant lymphoma. Here, we provide a review of the MGRS definition and related terminology and elaborate on the diagnostic approach and treatment principles from the general physician perspective.
引用
收藏
页码:250 / 253
页数:4
相关论文
共 50 条
  • [41] Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies
    Innao, Vanessa
    Allegra, Alessandro
    Ginaldi, Lia
    Pioggia, Giovanni
    De Martinis, Massimo
    Musolino, Caterina
    Gangemi, Sebastiano
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [42] Outcomes of non-AL monoclonal gammopathies of renal significance with clone-directed therapy
    Rubinstein, Samuel
    Peters, Daniel
    Lichtman, Eben
    Chakraborty, Rajshekhar
    Lentzsch, Suzanne
    Bhutani, Divaya
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S118 - S118
  • [43] From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance
    Visentin, Andrea
    Pravato, Stefano
    Castellani, Francesca
    Campagnolo, Marta
    Angotzi, Francesco
    Cavarretta, Chiara Adele
    Cellini, Alessandro
    Ruocco, Valeria
    Salvalaggio, Alessandro
    Tedeschi, Alessandra
    Trentin, Livio
    Briani, Chiara
    CANCERS, 2022, 14 (06)
  • [44] Screening for monoclonal gammopathies of undetermined significance: A prospective study
    El Maataoui, Aissam
    Farhat, Sofia
    JOURNAL OF PUBLIC HEALTH IN AFRICA, 2025, 16 (01)
  • [45] Monoclonal gammopathies of undetermined significance How to predict their progression?
    Leleu, Xavier
    HEMATOLOGIE, 2005, 11 (05): : 304 - 305
  • [46] Significance of standard laboratory techniques in the monitoring of monoclonal gammopathies
    Marrak, Mariem
    Krir, Dhouha
    Zamali, Imen
    Nasri, Yosra
    Kebaier, Hayet
    Ben Sghaier, Ines
    Ben Hmid, Ahlem
    Ben Ahmed, Melika
    Galai, Yousr
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1112 - 1112
  • [48] The Importance of Being Significant: "Monoclonal Gammopathies of Neurological Significance"
    Sadeghian, Hamid
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2021, 48 (05) : 599 - 600
  • [49] IgM monoclonal gammopathies of clinical significance: diagnosis and management
    Khwaja, Jahanzaib
    D'Sa, Shirley
    Minnema, Monique C.
    Kersten, Marie Jose
    Wechalekar, Ashutosh
    Vos, Josephine M., I
    HAEMATOLOGICA, 2022, 107 (09) : 2037 - 2050
  • [50] MONOCLONAL AND MULTICLONAL GAMMOPATHIES AFTER RENAL-TRANSPLANTATION
    STANKO, CK
    JEFFERY, JR
    RUSH, DN
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (02) : 3330 - 3332